| Literature DB >> 23819020 |
Katarzyna Orlicka1, Eleanor Barnes, Emma L Culver.
Abstract
Immunosuppressive therapy is frequently used to treat gastrointestinal diseases such as inflammatory bowel disease, autoimmune hepatitis, IgG4-related disease (autoimmune pancreatitis and sclerosing cholangitis) and in the post-transplantation setting. These drugs interfere with the immune system. The main safety concern with their use is the risk of infections. Certain infections can be prevented or their impact minimized. Physicians must adopt preventative strategies and should have a high degree of suspicion to recognize infections early and treat appropriately. This article reviews the risk factors for infections, the mechanism of action of immunosuppressive therapy and proposes preventive strategies.Entities:
Keywords: IgG4-related disease; autoimmune hepatitis; immunosuppressive therapy; infections; inflammatory bowel diseases; prevention; transplantation; vaccination
Year: 2013 PMID: 23819020 PMCID: PMC3697844 DOI: 10.1177/2040622313485275
Source DB: PubMed Journal: Ther Adv Chronic Dis ISSN: 2040-6223 Impact factor: 5.091